Safety, Tolerability And Pharmacokinetics/Pharmacodynamic Assessment Of An Oral, Selective Prolyl-Trna Synthetase Inhibitor, Dwn12088, For The Treatment Of Idiopathic Pulmonary Fibrosis In Healthy Subjects
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2021)
Key words
Idiopathic Pulmonary Fibrosis,Fibrosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined